| [1] |
KELLEY M J,JAWIEN W,ORTEL T L,et al.Mutation of MYH9,encoding non-muscle myosin heavy chain A,in May-Hegglin anomaly[J]. Nat Genet,2000,26(1):106-108.
|
| [2] |
SERI M,CUSANO R,GANGAROSSA S,et al.Mutations in MYH9 result in the May-Hegglin anomaly,and Fechtner and Sebastian syndromes. The May-Hegglin/Fechtner Syndrome Consortium[J]. Nat Genet,2000,26(1):103-105.
|
| [3] |
KUNISHIMA S,KOJIMA T,MATSUSHITA T,et al.Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions(May-Hegglin anomaly/Sebastian syndrome)[J]. Blood,2001,97(4):1147-1149.
|
| [4] |
张之南,沈悌. 血液病诊断与疗效判断[M]. 3 版. 北京:科学出版社,2007:10.
|
| [5] |
李德艳,高峰,郝冀洪,等. 一个May-Hegglin 异常家系MYH9基因突变位点研究[J]. 中华血液杂志,2012,33(8):660-662.
|
| [6] |
尚红,王毓三,申子瑜. 全国临床检验操作规程[M]. 4版. 北京:人民卫生出版社,2015:40.
|
| [7] |
HEATH K E,CAMPOS-BARROS A,TOREN A,et al.Nonmuscle myosin heavy chain ⅡA mutations define a spectrum of autosomal dominant macrothrombocytopenias:May-Hegglin anomaly and Fechtner,Sebastian,Epstein,and Alport-like syndromes[J]. Am J Hum Genet,2001,69(5):1033-1045.
|
| [8] |
DONG F,LI S,PUJOL-MOIX N,et al.Genotype-phenotype correlation in MYH9-related thrombocytopenia[J]. Br J Haematol,2005,130(4):620-627.
|
| [9] |
KUNISHIMA S,MATSUSHITA T,KOJIMA T,et al.Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions[J]. J Hum Genet,2001,46(12):722-729.
|
| [10] |
SERI M,PECCI A,DI BARI F,et al.MYH9-related disease:May-Hegglin anomaly,Sebastian syndrome,Fechtner syndrome,and Epstein syndrome are not distinct entities but represent a variable expression of a single illness[J]. Medicine(Baltimore),2003,82(3):203-215.
|
| [11] |
ALTHAUS K,GREINACHER A.MYH9-related platelet disorders[J]. Semin Thromb Hemost,2009,35(2):189-203.
|
| [12] |
PECCI A,CANOBBIO I,BALDUINI A,et al.Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations[J]. Hum Mol Genet,2015,14(21):3169-3178.
|
